NCT01327339 - REQUIP RLS Post Marketing Surveillance | Biotech Hunter

Enrollment

755

Participants

Timeline

Start Date

April 1, 2006

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Restless Legs Syndrome

Interventions

DRUG

Ropinirole

Basically there is no treatment allocation. Subjects who would be administered of ropinirole at their physician's direction will be enrolled. Dosage regimen will be recommended according to the prescribing information. Subjects will be enrolled consecutively.